Anvisa called on the collegiate board to discuss next Tuesday (11), the opening of a public consultation on the cultivation of cannabis for medical and scientific purposes in Brazil.
Brazilian patients who need cannabidiol, a substance extracted from marijuana for therapeutic use, have access to the drug only through importation. The process is expensive and must be authorized by ANVISA annually.
ANVISA DÁ PRIMEIRO PASSO PARA REGULAR PLANTIO DE CANNABIS NO BRASIL
A Anvisa convocou a diretoria colegiada para dialogar na próxima terça (11), a abertura de consulta pública sobre o cultivo de cannabis para fins medicinais e científicos no Brasil
Pacientes brasileiros que precisam de canabidiol, substância extraída da maconha para uso terapêutico, têm acesso ao medicamento somente por meio de importação. O processo custa caro e precisa ser autorizado pela ANVISA anualmente.
This post was written in, English and Portuguese, please consider using Google Translate or other online translator to help you if you spoke other language.
---
| 
| 
| 
| 
| 
| 
| 
| 
Gif by @aleister
Know my curation trail project
link-
If you would like to delegate to GRAFFITY HUNTER project by @pataty69 you can do that by clicking on the following links:
10SP-25SP-50SP-100SP-250SP-500SP-1000SP-
Be sure to leave at least 50SP undelegated on your account.